NP47725a Emicizumab (Indication Specific)
Details
- Supplier(s)
- Roche Products Ltd
- Value
- GBP 3,120,312
- Topic
- Pharmaceutical products
- Published
- 18 September 2025
Tender description
Supply of Emicizumab (Indication Specific) to NHS Scotland. Lot 1: The Framework Agreement is for the supply of Emicizumab (Indication Specific) to NHS Scotland. The Framework Agreement has been awarded as a single supplier framework agreement to one (1) Framework Participant.
Timeline
- Completed: Award date27 August 2025
- Completed: Award published18 September 2025Current notice
About the buyer
NHS National Services Scotland is a public sector buyer in United Kingdom publishing tenders and awards on Stotles. Explore their procurement activity and find more opportunities like this one.
Relevant CPV codes
- 33600000 · Pharmaceutical products
Decision makers
Connect with the people behind this procurement.
| Contact name | Job title | Phone number | Work email |
|---|---|---|---|
| Head of Procurement | +44 •••• •••••• | ••••••••@nhs-national-services-scotland.gov | |
| Commercial Director | +44 •••• •••••• | ••••••••@nhs-national-services-scotland.gov | |
| Procurement Manager | +44 •••• •••••• | ••••••••@nhs-national-services-scotland.gov | |
| Category Lead | +44 •••• •••••• | ••••••••@nhs-national-services-scotland.gov | |
| Senior Buyer | +44 •••• •••••• | ••••••••@nhs-national-services-scotland.gov | |
| Contracts Manager | +44 •••• •••••• | ••••••••@nhs-national-services-scotland.gov |
6 similar open tenders
See more open tenders related to NP47725a Emicizumab (Indication Specific).
- Open tender
IMP Manufacture, Labelling and Packaging DPS
- Open tender
CPH037 - Enhanced Services (Pharmacies)
- Open tender
Potassium iodide tablets 2024-2026
Related buyers
Buyers similar to NHS National Services Scotland.
- 19£4.6m
- 9£1.1m
- 6£445.5k
- 4£964.7k
- 2£252.0k
- 1£4.4m
- 747£1.9bn
- 231£2.0bn
- 138£1.4bn
- 135£63.9m
Win more public sector contracts
Track every UK and Ireland tender in one place — set up alerts, find decision-makers, and never miss an opportunity.
